Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.08 USD | +0.96% | -1.22% | -30.06% |
05-24 | HC Wainwright Adjusts Legend Biotech Price Target to $73 From $86, Maintains Buy Rating | MT |
05-24 | Deutsche Bank Starts Legend Biotech With Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.06% | 7.67B | |
+8.38% | 114B | |
+10.13% | 104B | |
-11.69% | 22.5B | |
+1.60% | 22.57B | |
-11.21% | 17.95B | |
-41.90% | 16.48B | |
-16.00% | 15.82B | |
+2.28% | 13.55B | |
+20.54% | 10.99B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Transcript : Legend Biotech Corporation, Q1 2024 Earnings Call, May 13, 2024